274 related articles for article (PubMed ID: 28031418)
1. Peripheral Inflammatory Biomarkers for Myocardial Infarction Risk: A Prospective Community-Based Study.
Wu Z; Huang Z; Jin W; Rimm EB; Lichtenstein AH; Kris-Etherton PM; Wu S; Gao X
Clin Chem; 2017 Mar; 63(3):663-672. PubMed ID: 28031418
[TBL] [Abstract][Full Text] [Related]
2. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein is associated with disability independently of vascular events: the Northern Manhattan Study.
Dhamoon MS; Cheung YK; Moon YP; Wright CB; Willey JZ; Sacco R; Elkind MS
Age Ageing; 2017 Jan; 46(1):77-83. PubMed ID: 28181636
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory serum markers and risk and severity of prostate cancer: The PROCA-life study.
Stikbakke E; Richardsen E; Knutsen T; Wilsgaard T; Giovannucci EL; McTiernan A; Eggen AE; Haugnes HS; Thune I
Int J Cancer; 2020 Jul; 147(1):84-92. PubMed ID: 31583707
[TBL] [Abstract][Full Text] [Related]
5. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
6. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
7. Relationship between C-reactive protein and stroke: a large prospective community based study.
Liu Y; Wang J; Zhang L; Wang C; Wu J; Zhou Y; Gao X; Wang A; Wu S; Zhao X
PLoS One; 2014; 9(9):e107017. PubMed ID: 25191699
[TBL] [Abstract][Full Text] [Related]
8. Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?
Eltoft A; Arntzen KA; Wilsgaard T; Hansen JB; Mathiesen EB; Johnsen SH
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773576
[TBL] [Abstract][Full Text] [Related]
9. Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.
Smit JJ; Ottervanger JP; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; Zijlstra F; van 't Hof AW;
Am J Cardiol; 2008 Feb; 101(4):446-51. PubMed ID: 18312755
[TBL] [Abstract][Full Text] [Related]
10. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.
Su J; Cui L; Yang W; Shi H; Jin C; Shu R; Li H; Zeng X; Wu S; Gao X
PLoS One; 2019; 14(2):e0211946. PubMed ID: 30768617
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein, obesity, and the risk of arterial and venous thrombosis.
Horvei LD; Grimnes G; Hindberg K; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Aug; 14(8):1561-71. PubMed ID: 27208592
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
Small AM; Pournamdari A; Melloni GEM; Scirica BM; Bhatt DL; Raz I; Braunwald E; Giugliano RP; Sabatine MS; Peloso GM; Marston NA; Natarajan P
JAMA Cardiol; 2024 Apr; 9(4):385-391. PubMed ID: 38353970
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
Pokharel Y; Sharma PP; Qintar M; Lu Y; Tang Y; Jones P; Dreyer RP; Spertus JA
Atherosclerosis; 2017 Nov; 266():16-23. PubMed ID: 28946036
[TBL] [Abstract][Full Text] [Related]
14. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
[TBL] [Abstract][Full Text] [Related]
15. Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction - A report from the CHART-2 Study.
Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Saga C; Ikeno Y; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
Int J Cardiol; 2019 Oct; 293():17-24. PubMed ID: 31358306
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States.
Pagidipati NJ; Hellkamp AS; Sharma PP; Wang TY; Fonarow GC; Pencina M
Am Heart J; 2018 Oct; 204():151-155. PubMed ID: 30121016
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
Nyrnes A; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Skjelbakken T; Jørgensen L; Løchen ML
Gend Med; 2012 Dec; 9(6):536-547.e2. PubMed ID: 23046763
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of lipoprotein(a) and high-sensitivity C-reactive protein on the risk of all-cause and cardiovascular death in patients with acute myocardial infarction: a large prospective cohort study.
Wang Z; Tang J; Shi Q; Fang L; Liu N; Zhang J
Front Endocrinol (Lausanne); 2024; 15():1392859. PubMed ID: 38812817
[TBL] [Abstract][Full Text] [Related]
19. Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.
Chan MY; Neely ML; Roe MT; Goodman SG; Erlinge D; Cornel JH; Winters KJ; Jakubowski JA; Zhou C; Fox KAA; Armstrong PW; White HD; Prabhakaran D; Ohman EM; Huber K;
Clin Chem; 2017 Jul; 63(7):1214-1226. PubMed ID: 28515099
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, high-sensitivity C-reactive protein levels and the risk of new-onset atrial fibrillation: Results from the Kailuan Study.
Wang Z; Wang B; Li X; Zhang S; Wu S; Xia Y
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):102-109. PubMed ID: 33500102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
